Published in J Clin Microbiol on October 01, 1998
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol (2010) 3.46
Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol (2000) 2.62
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J Clin Microbiol (2009) 2.11
Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion. J Virol (2000) 2.00
Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe (2014) 1.98
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol (2004) 1.55
Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol (2000) 1.54
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
Long-term circulation of vaccine-derived poliovirus that causes paralytic disease. J Virol (2002) 1.37
Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol (2004) 1.29
Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol (2003) 1.26
A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol (2005) 1.23
Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol (2005) 1.22
Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J Virol (2001) 1.20
Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl Environ Microbiol (2008) 1.19
Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children. J Clin Microbiol (2000) 1.18
Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol (2006) 1.11
Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence. Viruses (2011) 1.08
Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol (2008) 1.06
Rhinovirus genome variation during chronic upper and lower respiratory tract infections. PLoS One (2011) 1.05
Estimating the extent of vaccine-derived poliovirus infection. PLoS One (2008) 1.05
Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLoS Pathog (2015) 1.05
The role of B lymphocytes in coxsackievirus B3 infection. Am J Pathol (1999) 1.02
Long-term excretion of vaccine-derived poliovirus by a healthy child. J Virol (2004) 1.02
Multiplex PCR method for identifying recombinant vaccine-related polioviruses. J Clin Microbiol (2004) 1.01
Spread of vaccine-derived poliovirus from a paralytic case in an immunodeficient child: an insight into the natural evolution of oral polio vaccine. J Virol (2005) 1.01
A spread-deficient cytomegalovirus for assessment of first-target cells in vaccination. J Virol (2010) 0.96
Genus-specific substitution rate variability among picornaviruses. J Virol (2011) 0.96
Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties. J Virol (2006) 0.96
High susceptibility for enterovirus infection and virus excretion features in Tunisian patients with primary immunodeficiencies. Clin Vaccine Immunol (2012) 0.96
Feasibility of quantitative environmental surveillance in poliovirus eradication strategies. Appl Environ Microbiol (2012) 0.95
Genomic variations in echovirus 30 persistent isolates recovered from a chronically infected immunodeficient child and comparison with the reference strain. J Clin Microbiol (2000) 0.93
Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya. BMC Infect Dis (2009) 0.93
beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis. Am J Pathol (2003) 0.93
Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs. BMC Infect Dis (2015) 0.93
Shedding of vaccine viruses with increased antigenic and genetic divergence after vaccination of newborns with monovalent type 1 oral poliovirus vaccine. J Virol (2009) 0.92
Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol (2011) 0.91
Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol (2010) 0.87
In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J Virol (2014) 0.86
Molecular evidence of persistent echovirus 13 meningoencephalitis in a patient with relapsed lymphoma after an outbreak of meningitis in 2000. J Clin Microbiol (2003) 0.85
Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. J Virol (2002) 0.83
Immunodeficiency-associated vaccine-derived poliovirus type 3 in infant, South Africa, 2011. Emerg Infect Dis (2012) 0.83
Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol (2006) 0.82
Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. Clin Vaccine Immunol (2014) 0.81
Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece. Appl Environ Microbiol (2007) 0.80
Estimating the risk of re-emergence after stopping polio vaccination. Front Microbiol (2012) 0.79
Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol (2003) 0.79
Sequential asymptomatic enterovirus infections in a patient with major histocompatibility complex class II primary immunodeficiency. J Clin Microbiol (2014) 0.79
Innate and adaptive immune responses against picornaviruses and their counteractions: An overview. World J Virol (2012) 0.78
Molecular and Phenotypic Characterization of a Highly Evolved Type 2 Vaccine-Derived Poliovirus Isolated from Seawater in Brazil, 2014. PLoS One (2016) 0.78
Highly divergent type 2 and 3 vaccine-derived polioviruses isolated from sewage in Tallinn, Estonia. J Virol (2013) 0.77
Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis. BMC Infect Dis (2016) 0.75
Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry. Front Immunol (2017) 0.75
A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol (1980) 113.75
The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci (1992) 44.38
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
RNA virus mutations and fitness for survival. Annu Rev Microbiol (1997) 10.06
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Antigenic structure of picornaviruses. Curr Top Microbiol Immunol (1990) 2.31
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol (1986) 2.17
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Intratypic serodifferentiation of poliomyelitis virus strains by strain-specific antisera. Intervirology (1979) 2.12
Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev Infect Dis (1987) 2.06
Serotype-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residues at positions of codon degeneracy. J Clin Microbiol (1998) 1.93
X-linked agammaglobulinemia: an analysis of 96 patients. Medicine (Baltimore) (1985) 1.85
Trypsin sensitivity of the Sabin strain of type 1 poliovirus: cleavage sites in virions and related particles. J Virol (1985) 1.84
Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. J Gen Virol (1987) 1.76
The primary immunodeficiencies. N Engl J Med (1995) 1.65
Identification of vaccine-related polioviruses by hybridization with specific RNA probes. J Clin Microbiol (1995) 1.65
The biologic principles of poliovirus eradication. J Infect Dis (1997) 1.61
Oligonucleotide mapping: evaluation of its sensitivity by computer-simulation. Nucleic Acids Res (1982) 1.24
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep (1997) 1.19
Inadequacy of mucosal IgM antibodies in selective IgA deficiency: excretion of attenuated polio viruses is prolonged. J Clin Immunol (1988) 1.17
Alteration in oligonucleotide fingerprint patterns of the viral genome in poliovirus type 2 isolated from paralytic patients. Infect Immun (1982) 1.14
Molecular epidemiology of polioviruses. Rev Infect Dis (1984) 1.01
Progress toward global polio eradication. J Infect Dis (1997) 1.00
Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis. MMWR Morb Mortal Wkly Rep (1997) 0.88
Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol (1999) 7.79
Typing of human enteroviruses by partial sequencing of VP1. J Clin Microbiol (1999) 5.08
Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis (2000) 4.82
Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol (1999) 4.72
A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med (1995) 4.21
Geographic distribution of wild poliovirus type 1 genotypes. Virology (1987) 4.03
Comparison of classic and molecular approaches for the identification of untypeable enteroviruses. J Clin Microbiol (2000) 3.99
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Enterovirus 71 infections and neurologic disease--United States, 1977-1991. J Infect Dis (1994) 3.31
Determinants and predictors of dengue infection in Mexico. Am J Epidemiol (1991) 3.08
Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res (1995) 2.98
Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol (1981) 2.81
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet (1996) 2.78
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans. Virology (1981) 2.64
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol (1981) 2.54
Detection and identification of vaccine-related polioviruses by the polymerase chain reaction. Virus Res (1991) 2.35
Trial of a supplemental dose of four poliovirus vaccines. N Engl J Med (2000) 2.35
Genotype-specific in vitro amplification of sequences of the wild type 3 polioviruses from Mexico and Guatemala. Virus Res (1992) 2.33
Protein processing map of poliovirus. J Virol (1984) 2.33
Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine. Lancet (1993) 2.24
Group-specific identification of polioviruses by PCR using primers containing mixed-base or deoxyinosine residue at positions of codon degeneracy. J Clin Microbiol (1996) 2.23
Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis (1997) 2.16
Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev (2000) 2.06
Space flight alters bacterial gene expression and virulence and reveals a role for global regulator Hfq. Proc Natl Acad Sci U S A (2007) 2.05
Stopping poliovirus vaccination after eradication: issues and challenges. Bull World Health Organ (2000) 2.00
Poliomyelitis: epidemiology and prophylaxis. 1. A longitudinal epidemiological survey in Kenya. Bull World Health Organ (1973) 1.96
Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. JAMA (1996) 1.93
Changes in three of the four coat proteins of oral polio vaccine strain derived from type 1 poliovirus. J Virol (1980) 1.91
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Comparative study of five methods for intratypic differentiation of polioviruses. J Clin Microbiol (1995) 1.83
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. Arthritis Rheum (1997) 1.78
Picornaviral VPg sequences are contained in the replicase precursor. J Virol (1980) 1.77
Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res (1998) 1.74
Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol (2000) 1.71
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2000) 1.67
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation. J Clin Microbiol (1999) 1.62
Molecular phylogeny of all human enterovirus serotypes based on comparison of sequences at the 5' end of the region encoding VP2. Virus Res (1998) 1.61
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication. Int J Epidemiol (2001) 1.53
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Molecular and antigenic characterization of a highly evolved derivative of the type 2 oral poliovaccine strain isolated from sewage in Israel. J Clin Microbiol (2000) 1.50
Role of enterovirus 71 in acute flaccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis (1996) 1.47
Serotype-specific identification of enterovirus 71 by PCR. J Clin Virol (2000) 1.44
Vaccine-associated paralytic poliomyelitis. N Engl J Med (1993) 1.39
Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis (1998) 1.38
Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin Sci (Lond) (1990) 1.31
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Outbreaks of paralytic poliomyelitis, 1976-1995. J Infect Dis (1997) 1.20
Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. Clin Infect Dis (2001) 1.20
Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Incidence of HIV among injection drug users entering drug treatment programs in four US cities. J Urban Health (2001) 1.17
Echovirus 30 infection and aseptic meningitis in parents of children attending a child care center. J Infect Dis (1994) 1.15
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Incidence of HIV infection in a New York City methadone maintenance treatment program. JAMA (1996) 1.11
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. J Rheumatol (1998) 1.07
A molecular and serologic evaluation of enteroviral involvement in human myocarditis. J Mol Cell Cardiol (1990) 1.05
Oligonucleotide probes for the specific detection of the wild poliovirus types 1 and 3 endemic to Brazil. Intervirology (1991) 1.04
Tetanus surveillance--United States, 1995-1997. MMWR CDC Surveill Summ (1998) 1.03
Specific detection of echoviruses 22 and 23 in cell culture supernatants by RT-PCR. J Med Virol (1999) 1.02
Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol (1993) 1.01
Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01
Molecular epidemiology of polioviruses. Rev Infect Dis (1984) 1.01
Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet (1994) 1.00
Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications. Virus Res (1991) 0.99
Oligonucleotide fingerprint analysis of enterovirus 70 isolates from the 1980 to 1981 pandemic of acute hemorrhagic conjunctivitis: evidence for a close genetic relationship among Asian and American strains. Infect Immun (1983) 0.99
High degree of genetic diversity of non-polio enteroviruses identified in Georgia by environmental and clinical surveillance, 2002-2005. J Med Microbiol (2010) 0.99
First reported outbreak of classical dengue fever at 1,700 meters above sea level in Guerrero State, Mexico, June 1988. Am J Trop Med Hyg (1992) 0.98
HIV incidence among injection drug users enrolled in a Los Angeles methadone program. JAMA (1995) 0.97
Distribution of wild type 1 poliovirus genotypes in China. J Infect Dis (1993) 0.96
Acute hemorrhagic conjunctivitis due to enterovirus 70 in American Samoa: serum-neutralizing antibodies and sex-specific protection. Am J Epidemiol (1992) 0.96
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci (1995) 0.96
Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J (2001) 0.96
Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis (2001) 0.95
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95
Type-specific detection of echovirus 30 isolates using degenerate reverse transcriptase PCR primers. J Clin Microbiol (2001) 0.94
An outbreak of acute haemorrhagic conjunctivitis in Melaka, Malaysia. Singapore Med J (2003) 0.93
Chronic group A coxsackievirus infection in agammaglobulinemia: demonstration of genomic variation of serotypically identical isolates persistently excreted by the same patient. J Infect Dis (1988) 0.93
Geographical genotypes (geotypes) of poliovirus case isolates from the former Soviet Union: relatedness to other known poliovirus genotypes. J Gen Virol (1995) 0.93
Outbreak of paralytic poliomyelitis in a highly immunized population in Jordan. J Infect Dis (1997) 0.93
Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3. J Med Virol (1997) 0.93
A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. Vaccine (2013) 0.90
Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89
Tetanus associated with body piercing. Clin Infect Dis (1998) 0.88
Vaccine-preventable disease susceptibility in a young adult Micronesian population. Southeast Asian J Trop Med Public Health (1994) 0.88
A theoretical framework for evaluating the sensitivity of surveillance for detecting wild poliovirus: II. Factors affecting detection sensitivity in a population with circulating wild poliovirus. J Infect Dis (1997) 0.86
Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group. J Infect Dis (1995) 0.85